Stay on top of the latest research and practice
Industry symposium 1
Organised by AstraZeneca
Chair: Andreas du Bois (Germany)
12:30-12:35 Chair’s welcome and introductions Andreas du Bois (Germany)
12:35-12:50 Bringing BRCA into focus: Key considerations for implementing personalised medicine based on BRCA status Susana Banerjee (United Kingdom)
12:50-13:05 Placing HRD under the lens: The role of genomic instability testing in optimising patient car Thomas Herzog (USA)
13:05-13:10 Summary and meeting close Andreas du Bois (Germany)
13:10-13:30 Panel discussion and Q&A
Industry symposium 3
Organised by GSK
Chair: David Cibula (Czech Republic)
15:00-15:05 First-line maintenance therapy and the treatment landscape in advanced ovarian cancer David Cibula (Czech Republic)
15:05-15:50 Patient case profiles and guided decision-making Susana Banerjee (United Kingdom), Kathleen Moore (USA)
15:50-16:00 Panel discussion: putting it into perspective
Industry symposium 4
Organised by Seagen
Chair: Ignace Vergote (Belgium)
15:00-15:05 Introduction Ignace Vergote (Belgium)
15:05-15:20 Perspectives on current treatment landscape for r/m CC Christian Marth (Austria), Ignace Vergote (Belgium)
15:20-15:35 Experts discuss future treatment modalities for r/m CC Isabelle Ray-Coquard (France), Mansoor Raza Mirza (Denmark)
15:35-15:50 Can ADCs change r/m CC treatment landscape? Domenica Lorusso (Italy), Ignace Vergote (Belgium)
15:50-16:00 Live Q&A
Industry symposium 5
Organised by Mersana Therapeutics
Chair: Nicole Concin (Austria)
13:00-13:20 The Unmet Medical Need and Antibody Drug Conjugate Targets in Platinum-Resistant Ovarian Cancer (PROC) Nicole Concin (Austria)
13:20-13:40 Antibody Drug Conjugates (ADCs) – Structure, Key Properties, and Mechanism of Action David Cibula (Czech Republic)
13:40-14:00 NaPi2b-ADC biological rationale and clinical development of upifitamab rilsodotin (UpRi, XMT- 1536) and lifastuzumab vedotin (LIFA) Isabelle Ray-Coquard (France)
Industry symposium 6
Organised by Ethicon
Chairs: Giovanni Antonio Tommaselli (Italy) and Philippe Grange (Germany)
Industry symposium 7
Chair: Mansoor Raza Mirza (Denmark)
15:30-15:35 Welcome and Introduction Mansoor Raza Mirza (Denmark)
15:35-15:50 Key Updates to EC Treatment Guidelines: Molecular Profiling Nicole Concin (Austria)
15:50-16:00 The Role of Immunotherapy in Patients with EC Mansoor Raza Mirza (Denmark)
16:00-16:15 The Future of Immunotherapy in EC Bhavana Pothuri (USA)
16:15-16:30 Q&A
Industry symposium 8
Organised by Intuitive
Chair: Giovanni Scambia (Italy)
15:30-15:45 The Intuitive Ecosystem – What Covid helped us to achieve Myriam Curet (USA)
15:45-16:05 Robotic GYN surgery during Covid, the Liverpool Women’s Experience Mohamed Otify (United Kingdom)
16:05-16:25 Tips and tricks to support a low-impact robotic surgery in Gynecology Jordi Ponce (Spain)
16:25-16:30 Q&A
ONLINE PART OF THE CONGRESS
Technology forum
Digital Integration of the OR: Enabling the future with a comprehensive, connected ecosystem
Speaker: Brian Miller (Chief Digital Officer, Intuitive)
Sponsored Talk
Endometrial Cancer Surgery - Considerations Around Obese and Elderly Patients
Speaker: Walter Gotlieb (Canada)
Not yet an ESGO member?
Join or renew today
Get notified on all news and activities right in your mailbox.
Find out More
100+ Webcasts on ESGO eAcademy
Explore it Now!
Great moments from ESGO 2019!
View it Now!
Register Now!